Oppenheimer analyst Justin Kim reiterated an Outperform rating and $12.00 price target on Aldeyra Therapeutics (NASDAQ: ALDX).The analyst commented: "Aldeyra ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE